Sherry Bullens

1.0k total citations
13 papers, 578 citations indexed

About

Sherry Bullens is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Sherry Bullens has authored 13 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Genetics and 3 papers in Physiology. Recurrent topics in Sherry Bullens's work include Virus-based gene therapy research (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). Sherry Bullens is often cited by papers focused on Virus-based gene therapy research (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). Sherry Bullens collaborates with scholars based in United States and France. Sherry Bullens's co-authors include Stuart Bunting, Charles O’Neill, Beat A. Kaufmann, J. Todd Belcik, Jonathan R. Lindner, Aris Xie, Yue Qi, Sean Bell, Florence Lorget and Jeff Peng and has published in prestigious journals such as Journal of Biological Chemistry, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Sherry Bullens

13 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sherry Bullens United States	10	275	231	99	81	71	13	578
Nathalie Wunderlich Germany	13	265 1.0×	140 0.6×	92 0.9×	16 0.2×	70 1.0×	17	554
Mohamad Amer Alaiti United States	9	449 1.6×	40 0.2×	89 0.9×	199 2.5×	36 0.5×	28	719
Francine E. Carrick United States	9	308 1.1×	50 0.2×	134 1.4×	63 0.8×	30 0.4×	10	604
Ning-Yuan Chen United States	11	185 0.7×	112 0.5×	36 0.4×	42 0.5×	24 0.3×	11	562
Ramin Rabbani United States	6	95 0.3×	225 1.0×	74 0.7×	65 0.8×	20 0.3×	11	583
Bariş Boyraz United States	12	277 1.0×	60 0.3×	134 1.4×	38 0.5×	55 0.8×	27	619
Dylan Johnson United States	12	178 0.6×	122 0.5×	29 0.3×	147 1.8×	21 0.3×	20	545
Shimiao Zhu China	19	525 1.9×	93 0.4×	192 1.9×	47 0.6×	46 0.6×	38	1.0k
Paola Ferro Italy	15	132 0.5×	67 0.3×	125 1.3×	76 0.9×	103 1.5×	50	588
Daniel H. Y. Shen Taiwan	11	152 0.6×	98 0.4×	64 0.6×	17 0.2×	155 2.2×	19	498

Countries citing papers authored by Sherry Bullens

Since Specialization

Citations

This map shows the geographic impact of Sherry Bullens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry Bullens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry Bullens more than expected).

Fields of papers citing papers by Sherry Bullens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherry Bullens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry Bullens. The network helps show where Sherry Bullens may publish in the future.

Co-authorship network of co-authors of Sherry Bullens

This figure shows the co-authorship network connecting the top 25 collaborators of Sherry Bullens. A scholar is included among the top collaborators of Sherry Bullens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherry Bullens. Sherry Bullens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Yates, Bridget, Lin Xie, Ashrafali Mohamed Ismail, et al.. (2023). Prophylactic Prednisolone Promotes AAV5 Hepatocyte Transduction Through the Novel Mechanism of AAV5 Coreceptor Platelet-Derived Growth Factor Receptor Alpha Upregulation and Innate Immune Suppression. Human Gene Therapy. 35(1-2). 36–47. 3 indexed citations

Ismail, Ashrafali Mohamed, Bridget Yates, Lin Xie, et al.. (2022). Vector genome loss and epigenetic modifications mediate decline in transgene expression of AAV5 vectors produced in mammalian and insect cells. Molecular Therapy. 30(12). 3570–3586. 30 indexed citations

Agrawal, Vishal, Glenn Pacheco, Alessandra d’Azzo, et al.. (2020). Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency. Journal of Biological Chemistry. 295(39). 13556–13569. 9 indexed citations

Berguig, Geoffrey Y., Nathan Martin, Lin Xie, et al.. (2019). Of mice and men: Plasma phenylalanine reduction in PKU corrects neurotransmitter pathways in the brain. Molecular Genetics and Metabolism. 128(4). 422–430. 15 indexed citations

Zhang, Lening, Choong‐Ryoul Sihn, Lin Xie, et al.. (2019). Prednisolone Does Not Regulate Factor VIII Expression in Mice Receiving AAV5-hFVIII-SQ: Valoctocogene Roxaparvovec. Molecular Therapy — Methods & Clinical Development. 17. 13–20. 9 indexed citations

Bunting, Stuart, Lening Zhang, Lin Xie, et al.. (2017). Gene Therapy with BMN 270 Results in Therapeutic Levels of FVIII in Mice and Primates and Normalization of Bleeding in Hemophilic Mice. Molecular Therapy. 26(2). 496–509. 59 indexed citations

Bullens, Sherry, Florence Lorget, Sean Bell, et al.. (2015). Neutral Endopeptidase-Resistant C-Type Natriuretic Peptide Variant Represents a New Therapeutic Approach for Treatment of Fibroblast Growth Factor Receptor 3–Related Dwarfism. Journal of Pharmacology and Experimental Therapeutics. 353(1). 132–149. 88 indexed citations

Li, Shijie, Paul Kievit, Ganesh Kolumam, et al.. (2013). Targeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaques. Molecular Metabolism. 2(3). 256–269. 36 indexed citations

Kamath, Amrita V., Simon P. Williams, Sherry Bullens, et al.. (2012). Pharmacokinetics and Biodistribution of a Human Monoclonal Antibody to Oxidized LDL in Cynomolgus Monkey Using PET Imaging. PLoS ONE. 7(9). e45116–e45116. 3 indexed citations

10.

Belcik, J. Todd, Yue Qi, Beat A. Kaufmann, et al.. (2012). Cardiovascular and Systemic MicrovascularEffects of Anti-Vascular Endothelial Growth Factor Therapy for Cancer. Journal of the American College of Cardiology. 60(7). 618–625. 42 indexed citations

11.

Spilman, Patricia, Jon Vincelette, Andrew McGeehan, et al.. (2012). S4‐04‐04: The APP ligand Netrin‐1 improves memory and biomarkers after ICV administration in PD APP mice. Alzheimer s & Dementia. 8(4S_Part_20). 1 indexed citations

12.

Lorget, Florence, Nabil Kaci, Jeff Peng, et al.. (2012). Evaluation of the Therapeutic Potential of a CNP Analog in a Fgfr3 Mouse Model Recapitulating Achondroplasia. The American Journal of Human Genetics. 91(6). 1108–1114. 140 indexed citations

13.

Kaufmann, Beat A., Chad L. Carr, J. Todd Belcik, et al.. (2009). Molecular Imaging of the Initial Inflammatory Response in Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 30(1). 54–59. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact